Persistent infection with ebola virus under conditions of partial immunity.
about
Ebola haemorrhagic feverAerosol Transmission of FilovirusesMouse models for filovirus infectionsNeutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against itAcquired immunity and asymptomatic reservoir impact on frontline and airport ebola outbreak syndromic surveillance and response.Molecular determinants of Ebola virus virulence in mice.Biomarker correlates of survival in pediatric patients with Ebola virus disease.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.Progress in filovirus vaccine development: evaluating the potential for clinical use.Filovirus-like particles as vaccines and discovery tools.Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers.Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virusLongitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.Correlates of immunity to filovirus infection.Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.Characterization of host immune responses in Ebola virus infections.Development of experimental and early investigational drugs for the treatment of Ebola virus infections.Small Animal Models for Studying Filovirus Pathogenesis.Ebola virus infection modeling and identifiability problems.A strategy to simultaneously eradicate the natural reservoirs of rabies and Ebola virus.CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.Immune barriers of Ebola virus infection.
P2860
Q24629338-24E63A96-B49C-453C-B1DF-594AD5CEA603Q26745989-EF29D95A-81C0-4375-900F-1519166C353CQ27011569-9D25FA0C-6F99-4D54-802B-5FB3E9BE123BQ27489891-C65705D3-F4C5-4F73-B2C6-D1304BCC9E1FQ28649707-2BEB9638-3DA6-4E5C-97BE-1F1EAC775091Q33250567-55B110A4-87A8-45CC-8C58-A4F86E9A6F88Q34320456-E0107BD6-B2EE-4F6E-A4D9-9C6527CA51E0Q34971349-CA687B7D-43AC-414D-ABA2-8B8F0280E9E1Q35193052-3A61FBA7-7880-4A03-9FFD-947EE13BD532Q36100545-2F8CC439-FC02-4BF2-9631-023FB58261E4Q36198685-85F48AC1-32C4-47DC-AA18-B759F105202AQ36482804-97C786B4-C04C-4F77-8C9E-33C15DFD0B5DQ36484103-733A4511-B9D2-428B-8B7F-7D535B168750Q36775011-A2EB9988-8026-4026-9590-895343448EEAQ36960705-4AC85AC5-DB94-4E46-A47F-79DB3E9E2B0DQ37945233-DC5D1763-8F46-40B2-A949-6F727CEDC05DQ37976671-CC375A77-1B5E-441B-8FAD-7BACD854512AQ38205274-C764A1B0-1468-45FC-A7ED-EA52B1987FC0Q38524949-42104ACA-60D1-41DD-8525-55828E9DFCC2Q38666317-3DFC1581-E01A-493F-83BF-F775025F90C8Q39013896-58C85A41-F272-4428-818D-48005D4BD573Q40297083-70A9045D-031F-4535-8DFF-7B6AB08CB666Q40314624-86509B79-F186-40B6-9B24-E89E2E6C4F32Q49917351-A88C386C-6967-4A12-BAB1-EB131020D920
P2860
Persistent infection with ebola virus under conditions of partial immunity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Persistent infection with ebola virus under conditions of partial immunity.
@en
type
label
Persistent infection with ebola virus under conditions of partial immunity.
@en
prefLabel
Persistent infection with ebola virus under conditions of partial immunity.
@en
P2093
P2860
P50
P1433
P1476
Persistent infection with ebola virus under conditions of partial immunity.
@en
P2093
Manisha Gupta
Patricia Greer
Rafi Ahmed
Wun-Ju Shieh
P2860
P304
P356
10.1128/JVI.78.2.958-967.2004
P407
P577
2004-01-01T00:00:00Z